Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-06 Sale | 2023-03-08 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 77,421 | $9.5536 | $739,653 | 165,381 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 07:33 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 59,655 | $9.8866 | $589,785 | 182,727 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 10,897 | $7.4082 | $80,727 | 408,324 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 07:43 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 4,862 | $8.1422 | $39,587 | 134,149 (Direct) | View |
| 2022-02-09 Sale | 2022-02-10 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 4,138 | $9.0602 | $37,491 | 124,912 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-03 Option Award | 2023-03-07 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 99,601 | $0 | 507,925 (Direct) | View |
| 2023-03-04 Exercise | 2023-03-07 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 77,421 | $0 | 507,925 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-02 07:33 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 59,655 | $0 | 182,727 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 07:02 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 42,309 | $0 | 42,309 (Direct) | View |
| 2022-03-04 Option Award | 2022-03-08 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 154,155 | $0 | 408,324 (Direct) | View |
| 2022-03-04 Exercise | 2022-03-08 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 76,821 | $0 | 408,324 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-02 07:43 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 17,346 | $0 | 134,149 (Direct) | View |
| 2022-02-08 Option Award | 2022-02-10 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 37,939 | $0 | 124,912 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-10 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial | 13,135 | $0 | 124,912 (Direct) | View |